COMMUNIQUÉS West-GlobeNewswire

2019 half-year financial report
25/07/2019
Press release 25 July 2019 Embargo till 08:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, day-to-day management, aspijcke@icloud.com 2019 half-year financial report [...]
Rapport financier semestriel 2019
25/07/2019
Communiqué de presse 25 juillet 2019 Embargo jusqu’à 08:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: Anne Sophie Pijcke, directeur, aspijcke@icloud.com Rapport financier semestriel [...]
Ossur Hf : Interim report Q2 2019
25/07/2019
Announcement no. 44/2019 Interim report Q2 2019 25 July 2019 Highlights Sales growth of 18% in local currency in Q2 2019 and organic sales growth of 7%. Sales growth of 19% in local currency in 1H 2019 and organic sales [...]
Genkyotex Announces Positive Post-Hoc Analysis of PBC Phase 2 Trial and Reports Cash Position at June 30, 2019
25/07/2019
Setanaxib (GKT831) achieved statistical significance (p=0.02) for primary endpoint with the 400mg BID versus placebo, after correction of non-normal distribution (outliers) in 400mg OD In advanced patients, setanaxib [...]
Genkyotex Annonce Les Résultats Favorables de L’analyse Post-Hoc de L’essai de Phase 2 Dans la CBP et Publie sa Situation de Trésorerie au 30 Juin 2019
25/07/2019
Le setanaxib (GKT831) atteint la signification statistique (p=0,02) pour le critère d’efficacité principal à 400mg BID contre placébo, après correction des aberrations de distribution à 400mg OD Chez les patients à un [...]
argenx to report half year 2019 financial results and second quarter business update on August 1, 2019
25/07/2019
July 25, 2019 Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Number of shares and voting rights of Innate Pharma as at July 17, 2019
25/07/2019
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS AT JULY 17, 2019 Marseille, France, July 25, 2018, 7:00 AM CET Pursuant to the article L. 233-8 II of the French « Code de Commerce » and the article 223-16 of the [...]
Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 17 juillet 2019
25/07/2019
NOUVEAU NOMBRE D’ACTIONS ET DE DROITS DE VOTE D’INNATE PHARMA AU 17 JUILLET 2019 Marseille, le 25 juillet 2019, 7h00 CET Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l’ [...]
CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine
25/07/2019
CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine Oslo, Norway, and Saint-Herblain, France, July 25, 2019 —Valneva SE (“Valneva”), a biotech company developing [...]
CEPI octroie un financement à Valneva d’une valeur maximale de $23.4 millions pour le développement avancé d’un vaccin à injection unique contre le chikungunya
25/07/2019
CEPI octroie un financement à Valneva d’une valeur maximale de $23.4 millions pour le développement avancé d’un vaccin à injection unique contre le chikungunya Oslo, Norvège et Saint-Herblain, France, 25 juillet 2019 — [...]
Pixium Vision announces H1 2019 financial results and provides business update
25/07/2019
12-month data confirm and extend 6-month results in Prima System feasibility study Engaging with regulators to design development plan for Prima System in US Evaluating potential for parallel development in US and [...]
Pixium Vision annonce ses résultats financiers au 30 juin 2019 et fait le point sur ses activités
25/07/2019
Confirmation de résultats cliniques meilleurs qu’attendus à 12 mois avec le système Prima Mise en œuvre d’un plan d’action auprès des autorités réglementaires pour définir le plan de développement du système Prima aux [...]
Roche reports very strong performance in the first half of 2019 – Outlook raised
25/07/2019
Basel, 25 July 2019 Group sales increase 9% 1 at constant exchange rates and 8% in Swiss francs Pharmaceuticals Division sales up 10%, driven mainly by Ocrevus, Hemlibra, Tecentriq and Perjeta Diagnostics Division sales [...]
Roche affiche une très bonne performance au premier semestre 2019 – prévisions pour l’année révisées à la hausse
25/07/2019
Bâle, le 25 juillet 2019 Le chiffre d’affaires consolidé augmente de 9% 1 à taux de change constants et de 8% en francs suisses Le chiffre d’affaires de la division Pharma est en hausse de 10%, porté principalement par [...]
Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China
25/07/2019
PISCATAWAY, N.J., July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta), a technology based company focusing on the development and commercialization of Branded Specialty Products, today announced that [...]
MediciNova Appoints Kazuko Matsuda to its Board of Directors
25/07/2019
LA JOLLA, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Cara Therapeutics Announces Pricing of $126.5 Million Offering of Common Stock
25/07/2019
STAMFORD, Conn., July 24, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
Livongo Announces Pricing of Initial Public Offering
25/07/2019
MOUNTAIN VIEW, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (Livongo) today announced the pricing of its initial public offering of 12,687,000 shares of its common stock at a price of $28.00 per share [...]
Ascent Industries Announces That David Kennedy Joins as Operations Director-Nevada
25/07/2019
VANCOUVER, British Columbia, July 24, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. (CSE: ASNT) (“Ascent”) announces David Kennedy is joining the new management team to lead operations at the Las Vegas, Nevada [...]

Pages